By Will Feuer ArriVent BioPharma, a clinical-stage biopharmaceutical company, filed for an initial public offering. The company plans to list its stock on.
Chronic Inflammatory Demyelinating Polyneuropathy Market to Register Positive Growth During the Study Period (2019-2032), Evaluates DelveInsight | Key Companies to Watch Out lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
The British pharmaceutical giant AstraZeneca Plc will argue before Delaware’s Court of Chancery this week that claims it pushed biotech company Viela Bio Inc. into a sale with another drug company to avoid potential antitrust concerns are “fanciful allegations.”
/PRNewswire/ The "Global CD19 Antibody Market and Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com s offering. CD19 targeting.
J&J's medtech chief out the door—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.